AB
JBIO

Amalgamated Bank’s Jade Biosciences JBIO Stock Holding History

Amalgamated Bank’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,454
Closed -$22K – 1737
2025
Q4 		$22K Buy
1,454
+1,445
+16,056% +$17K ﹤0.01% 2060
2025
Q3 		$0 Hold
9
– – ﹤0.01% 2993
2025
Q2 		$0 Sell
9
-1
-10% -$34 ﹤0.01% 3022
2025
Q1 		$1K Hold
10
– – ﹤0.01% 2900
2024
Q4 		$1K Hold
10
– – ﹤0.01% 2942
2024
Q3 		$1K Hold
10
– – ﹤0.01% 2960
2024
Q2 		$1K Hold
10
– – ﹤0.01% 2977
2024
Q1 		$10K Sell
10
-31
-76% -$23.7K ﹤0.01% 2423
2023
Q4 		$32K Sell
41
-3
-7% -$1.53K ﹤0.01% 2432
2023
Q3 		$21K Hold
44
– – ﹤0.01% 2625
2023
Q2 		$26K Buy
44
+16
+57% +$10.2K ﹤0.01% 2601
2023
Q1 		$20K Sell
28
-6
-18% -$4.98K ﹤0.01% 2640
2022
Q4 		$35K Hold
34
– – ﹤0.01% 2572
2022
Q3 		$20K Hold
34
– – ﹤0.01% 2812
2022
Q2 		$19K Sell
34
-8
-19% -$3.82K ﹤0.01% 2866
2022
Q1 		$27K Buy
+42
New +$16.3K ﹤0.01% 2706

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Amalgamated Bank's JBIO Position: Q1 2026 in Review

Amalgamated Bank sold out of Jade Biosciences (JBIO) in Q1 2026, closing a stake of 1,454 shares — an estimated $22K sold.

Amalgamated Bank first reported a position in JBIO in Q1 2022 and held it in 16 quarters. The position peaked at $35K in Q4 2022. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Amalgamated Bank reported no remaining Jade Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,454 Jade Biosciences shares in Q1 2026, an estimated $22K.
  • Amalgamated Bank first reported a position in Jade Biosciences in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Jade Biosciences position peaked at $35K in Q4 2022.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.